1. Home
  2. AGEN vs MED Comparison

AGEN vs MED Comparison

Compare AGEN & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$2.98

Market Cap

126.2M

Sector

Health Care

ML Signal

HOLD

Logo MEDIFAST INC

MED

MEDIFAST INC

HOLD

Current Price

$10.80

Market Cap

120.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGEN
MED
Founded
1994
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
126.2M
120.6M
IPO Year
1999
1996

Fundamental Metrics

Financial Performance
Metric
AGEN
MED
Price
$2.98
$10.80
Analyst Decision
Buy
Hold
Analyst Count
2
1
Target Price
$14.50
$12.00
AVG Volume (30 Days)
381.7K
235.8K
Earning Date
01-01-0001
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.37
N/A
Revenue
$42,877,086.00
$934,842,000.00
Revenue This Year
$5.19
N/A
Revenue Next Year
$68.25
N/A
P/E Ratio
$7.88
N/A
Revenue Growth
89.95
N/A
52 Week Low
$1.38
$10.10
52 Week High
$7.34
$15.37

Technical Indicators

Market Signals
Indicator
AGEN
MED
Relative Strength Index (RSI) 43.35 47.28
Support Level $2.90 $10.19
Resistance Level $3.15 $12.08
Average True Range (ATR) 0.18 0.38
MACD 0.00 0.04
Stochastic Oscillator 15.79 67.38

Price Performance

Historical Comparison
AGEN
MED

About AGEN Agenus Inc.

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).

About MED MEDIFAST INC

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

Share on Social Networks: